RenoVō® Equine Revenue

About RenoVō® Equine

RenoVō® is a liquid, acellular, equine amniotic tissue allograft comprised of amnion and amniotic fluid, intended to supplement and protect tissues. Amnion and amniotic fluid are rich sources of biologically active factors involved in tissue regeneration with reported anti-inflammatory, anti-bacterial, re-epithelialization, and anti-fibrotic properties. Amniotic tissues contain key growth factors, cytokines, amino acids, hyaluronic acid, and extracellular matrix proteins recognized as intrinsic to the complex tissue healing process. RenoVō® is manufactured aseptically following cGTP guidelines and is supplied cryopreserved in three volumes: 1.5 cc, 3.0 cc, and 5.0 cc. The product is stored frozen at -80˚C +/- 15˚C with a 2-year shelf life or at -20˚C +/- 2˚C for up to 6 months. Ready availability of an allograft potentiates clinical use without having time lapse for harvesting techniques required for PRP, A2M and other autologous platforms. The protein content and reproducibility of RenoVō® offer a more consistent product with similar or superior regenerative capacity. RenoVō® is cryopreserved and maintained frozen before use, so as to preserve beneficial proteins that may not survive lyophilization or room temperature conditions. RenoVō® has been used in over 17,000 horses to date and is enjoying strong interest among veterinarians and owners as a superior alternative to autologous and other therapies. For more information visit http://www.renovoequine.com

View contact profiles from RenoVō® Equine